We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Omega-3 Found to Increase Brain's Gray Matter

By Biotechdaily staff writers
Posted on 22 Mar 2007
Omega-3 fatty acids, found in fatty fish such as salmon, are associated with increased gray matter volume in areas of the brain typically linked to mood and behavior according to new research.

The study's results were presented March 6, 2007, by Sarah M. More...
Conklin, Ph.D., postdoctoral scholar at the Cardiovascular Behavioral Medicine Program in the department of psychiatry at the University of Pittsburgh (Pitt; PA, USA), at the American Psychosomatic Society's annual meeting, held in Budapest, Hungary.

Animal studies have shown that raising omega-3 intake leads to structural brain alteration. In a separate study presented by Dr. Conklin at the society's meeting in 2006, Pitt researchers reported that people who had lower blood levels of omega-3 fatty acids were more apt to have a negative outlook and be more impulsive. On the other hand, those with higher blood levels of omega-3s were found to be more agreeable and less likely to report mild or moderate symptoms of depression. In this study, the researchers tried to determine if gray matter volume was proportionally related to long-chain omega-3 intake in humans, particularly in areas of the brain related to mood, helping them attempt to elucidate the processes behind the improvement in mood often associated with long-chain omega-3 intake.

Researchers interviewed 55 healthy adult participants to determine their average intake of long-chain omega-3 fatty acids. Gray matter volume was assessed using high-resolution structural magnetic resonance imaging (MRI).

The researchers discovered that participants who had high levels of long-chain omega-3 fatty acid intake had higher volumes of gray matter in areas of the brain associated with emotional arousal and regulation--the bilateral anterior cingulate cortex, the right amygdala and the right hippocampus.

While this finding suggests that omega-3s may promote structural improvement in areas of the brain related to mood and emotion regulation--the same areas where gray matter is decreased in individuals who have mood disorders such as major depressive disorder--investigators noted that more research is needed to determine whether fish consumption actually causes changes in the brain.


Related Links:
University of Pittsburgh

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
All-in-One Molecular System
AIO M160
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.